Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics.
<h4>Background</h4>Testing for tumor specific mutations on routine formalin-fixed paraffin-embedded (FFPE) tissues may predict response to treatment in Medical Oncology and has already entered diagnostics, with KRAS mutation assessment as a paradigm. The highly sensitive real time PCR (Q...
Guardado en:
Autores principales: | Vassiliki Kotoula, Elpida Charalambous, Bart Biesmans, Andigoni Malousi, Eleni Vrettou, George Fountzilas, George Karkavelas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e241b17456aa4daf9e42a247a3ac19c2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
KRAS mutation: from undruggable to druggable in cancer
por: Lamei Huang, et al.
Publicado: (2021) -
Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations
por: Satoshi Inoue, et al.
Publicado: (2019) -
Capturing the primordial Kras mutation initiating urethane carcinogenesis
por: Siqi Li, et al.
Publicado: (2020) -
KRAS insertion mutations are oncogenic and exhibit distinct functional properties
por: Yasmine White, et al.
Publicado: (2016) -
The origins and genetic interactions of KRAS mutations are allele- and tissue-specific
por: Joshua H. Cook, et al.
Publicado: (2021)